- Geopolitics ‘chills’ British biotech IPO plans, despite $2B in Q2 VC fundsGeopolitical uncertainty has continued to “chill” IPO sentiment among British biotechs, an industry leader has told Fierce, even as the sector saw second-quarter venture capital funding reach a fiv…Fierce Biotech · 9d ago↗ source
- Abbott hit by cyberattack on cancer diagnostics, LabCentral portal businessesAbbott has been struck by several cyberattacks which targeted the medtech giant’s cancer diagnostics and LabCentral businesses.Fierce Biotech · 9d ago↗ source
- Biogen’s mixed Alzheimer’s data; Two new startups launch; and moreWelcome back to another edition of Endpoints Weekly! We hope you all have been staying safe indoors as the Canadian wildfires blanketed much of the US Northeast this week. Hopefully things calm dow…